Cleared Traditional

K232330 - Lancing System (FDA 510(k) Clearance)

Jan 2024
Decision
154d
Days
Class 2
Risk

K232330 is an FDA 510(k) clearance for the Lancing System. This device is classified as a Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature (Class II - Special Controls, product code QRK).

Submitted by Ningbo Medsun Medical Co., Ltd. (Ningbo, CN). The FDA issued a Cleared decision on January 4, 2024, 154 days after receiving the submission on August 3, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes..

Submission Details

510(k) Number K232330 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 2023
Decision Date January 04, 2024
Days to Decision 154 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QRK — Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.